Outpatient Partial Nephrectomy Safety Probed
Study reveals an elevated risk for cardiac arrest and 30-day mortality associated with outpatient vs inpatient minimally invasive partial nephrectomy.
Study reveals an elevated risk for cardiac arrest and 30-day mortality associated with outpatient vs inpatient minimally invasive partial nephrectomy.
Identifying which patients are at increased risk of conversion is important for shared decision making.
Use of cytoreductive nephrectomy with an immune checkpoint inhibitor reduced death risk by 67%.
Achieving normal blood pressure in childhood cancer survivors is “extremely important” for preventing CKD, according to investigators.
Study included a large, contemporary cohort of patients with T1a renal cell carcinoma undergoing partial nephrectomy or local tumor destruction.
An accurate estimate of future GFR after nephrectomy would help to guide operative strategy and use of adjuvant or neoadjuvant therapies, according to a recent editorial.
Investigators report a cumulative 10-year incidence of end-stage kidney disease of 2.5% among patients who undergo surgery for renal cell carcinoma (RCC), which is 10 times higher than in patients without RCC.
Cytoreductive partial nephrectomy and robotic radiosurgery appear to have a place in the treatment of metastatic renal cell carcinoma, research findings suggest.
Compared with type I, papillary RCC type II more frequently carries unfavorable tumor characteristics.
Positive surgical margins in patients undergoing robotic partial nephrectomy for renal tumors are associated with adverse oncologic outcomes, a study revealed.